Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CG | P48736 | 12/20 | 0.59 |
| ▸ | PIK3CA | P42336 | 8/20 | 0.59 |
| ▸ | PIK3CD | O00329 | 7/20 | 0.59 |
| ▸ | PIK3CB | P42338 | 7/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA11 | O75493 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CA3 | P07451 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | CA4 | P22748 | 1/20 | 0.54 |
| ▸ | CA6 | P23280 | 1/20 | 0.54 |
| ▸ | CA5A | P35218 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4854398 | 0.86 | PIK3CG (0.50) | PIK3CGPIK3CAPIK3CDPIK3CBMEN1 | |
| SCHEMBL10125972 | 0.86 | PIK3CG (0.57) | PIK3CGPIK3CAPIK3CDPIK3CBMEN1 | |
| Hydrochloric Acid SCHEMBL28106590 | 0.85 | RORA (0.49) | PIK3CGPIK3CAPIK3CDPIK3CBMEN1 | |
| SCHEMBL14269496 | 0.85 | RORA (0.49) | PIK3CGPIK3CAPIK3CDPIK3CBMEN1 | |
| SCHEMBL241490 | 0.85 | RORA (0.49) | PIK3CGPIK3CAPIK3CDPIK3CBMEN1 | |
| SCHEMBL14194329 | 0.85 | RORA (0.49) | PIK3CGPIK3CAPIK3CDPIK3CBMEN1 | |
| SCHEMBL5449950 | 0.85 | RORA (0.49) | PIK3CGPIK3CAPIK3CDPIK3CBMEN1 | |
| SCHEMBL12197706 | 0.83 | RORA (0.54) | PIK3CGPIK3CAPIK3CDPIK3CBMEN1 | |
| SCHEMBL2346078 | 0.83 | CA2 (0.54) | PIK3CGPIK3CAPIK3CDPIK3CBMEN1 | |
| SCHEMBL2027801 | 0.82 | RORA (0.47) | PIK3CGPIK3CAPIK3CDPIK3CBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260056191-A1 | POLYMERS AND CONJUGATES COMPRISING THE SAME | VENTANA MEDICAL SYSTEMS, INC. (US) | 2026-02-26 | — | — | US | claimed |
| US-20240123045-A1 | NONAUTOLOGOUS MULTI-STRESSED CANCER CELLS AND USES THEREOF FOR VACCINATING AND TREATING CANCERS | BRENUS PHARMA (FR) | 2024-04-18 | — | — | US | claimed |
| EP-4297874-A1 | NONAUTOLOGOUS MULTI-STRESSED CANCER CELLS AND USES THEREOF FOR VACCINATING AND TREATING CANCERS | BRENUS PHARMA (FR) | 2024-01-03 | — | — | EP | claimed |
| WO-2022180251-A1 | NONAUTOLOGOUS MULTI-STRESSED CANCER CELLS AND USES THEREOF FOR VACCINATING AND TREATING CANCERS | BRENUS PHARMA (FR) | 2022-09-01 | — | — | WO | claimed |
| US-11079372-B2 | Polymers and conjugates comprising the same | VENTANA MEDICAL SYSTEMS, INC. (US) | 2021-08-03 | — | — | US | claimed |
| US-10775281-B2 | Polymer stabilization of chromogen solutions | VENTANA MEDICAL SYSTEMS, INC. (US) | 2020-09-15 | — | — | US | claimed |
| EP-3276349-B1 | HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE | VENTANA MED SYST INC (US) | 2019-08-07 | — | — | EP | claimed |
| EP-2686438-B1 | A METHOD OF ANALYZING CHROMOSOMAL TRANSLOCATIONS AND A SYSTEM THEREFOR | VENTANA MED SYST INC (US) | 2018-04-18 | — | — | EP | claimed |
| EP-3276349-A1 | HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE | Ventana Medical Systems, Inc. (US) | 2018-01-31 | — | — | EP | claimed |
| EP-3201628-A2 | POLYMERS AND CONJUGATES COMPRISING THE SAME | Ventana Medical Systems, Inc. (US) | 2017-08-09 | — | — | EP | claimed |
| EP-3029461-A1 | HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE | Ventana Medical Systems, Inc. (US) | 2016-06-08 | — | — | EP | claimed |
| WO-2016050913-A2 | POLYMERS AND CONJUGATES COMPRISING THE SAME | VENTANA MEDICAL SYSTEMS, INC. (US) | 2016-04-07 | — | — | WO | claimed |
| EP-2686438-A1 | A METHOD OF ANALYZING CHROMOSOMAL TRANSLOCATIONS AND A SYSTEM THEREFORE | Ventana Medical Systems, Inc. (US) | 2014-01-22 | — | — | EP | claimed |
| CN-103534359-A | A method of analyzing chromosomal translocations and a system therefore | VENTANA MED SYST INC | 2014-01-22 | — | — | CN | claimed |
| EP-2539466-A1 | CYTOGENIC ANALYSIS OF METAPHASE CHROMOSOMES | Ventana Medical Systems, Inc. (US) | 2013-01-02 | — | — | EP | claimed |
| EP-2539355-A1 | POLYTAG PROBES | Ventana Medical Systems, Inc. (US) | 2013-01-02 | — | — | EP | claimed |
| US-20120301886-A1 | POLYTAG PROBES | VENTANA MEDICAL SYSTEMS, INC. | 2012-11-29 | — | — | US | claimed |
| US-20120301885-A1 | CYTOGENIC ANALYSIS OF METAPHASE CHROMOSOMES | TANG LEI (US) | 2012-11-29 | — | — | US | claimed |
| US-20120237930-A1 | METHOD OF ANALYZING CHROMOSOMAL TRANSLOCATIONS AND A SYSTEM THEREFORE | VENTANA MEDICAL SYSTEMS, INC. | 2012-09-20 | — | — | US | claimed |
| WO-2012123387-A1 | A METHOD OF ANALYZING CHROMOSOMAL TRANSLOCATIONS AND A SYSTEM THEREFORE | F. HOFFMANN-LA ROCHE AG (CH) | 2012-09-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260056191-A1 | POLYMERS AND CONJUGATES COMPRISING THE SAME | POLD1, POLL, INCENP | PIK3CG 1599/4885PIK3CA 601/4885PIK3CD 798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.